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Hepatic stellate cells (HSCs) activation is an initial event in liver ﬁbrosis. MicroRNAs (miRNAs) have
been found to play essential roles in cell differentiation, proliferation, and fat metabolism. In this
study, we showed that down-regulation of two over-expressed miRNAs, miR-27a and 27b allowed
culture-activated rat HSCs to switch to a more quiescent HSC phenotype, with restored cytoplasmic
lipid droplets and decreased cell proliferation. Mechanistically, retinoid X receptor awas conﬁrmed
to be the target of miR-27a and 27b. These results indicated a new role and mechanism of miR-27a
and 27b in regulating fat metabolism and cell proliferation during HSCs activation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hepatic stellate cells (HSCs) normally reside in the space of Dis-
se, containing bunches of vitamin A-riching lipid droplets, while
activated HSCs lose cytoplasmic lipid droplets and trans-differenti-
ate to proliferative, ﬁbrogenic myoﬁbroblasts, and play an essential
role in the formation of liver ﬁbrosis [1]. We hypothesized that
microRNA (miRNA) could take part in such transdifferentiation.
MiRNAs are endogenous small (22nt) non-coding RNAs that
regulate gene expression by speciﬁcally interacting with
30untranslated region (30UTR) of target gene mRNAs to repress
translation or enhance mRNA cleavage [2], and play essential roles
in a variety of cellular processes, including cell differentiation, pro-
liferation, and fat metabolism [3–6]. Recently, miRNAs have caused
tremendous excitement in cancer research [7,8]. Their relationshipchemical Societies. Published by E
U, bromodeoxyuridine; HSCs,
microRNA; MRE, microRNA
TR, 30untranslated region
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[9,10]. Identiﬁcation of abnormally expressed miRNAs in patho-
logic state will be helpful to further understand the mechanism
of disease and modulation of their activity may be of therapeutic
beneﬁt [11]. However, the role of miRNAs in liver ﬁbrosis has not
been addressed.
In this study, we focused on two miRNAs (27a and 27b) that
over-expressed in primary culture-activated rat HSCs. Down-regu-
lation of miR-27a and 27b allowed culture-activated rat HSCs to
switch to a more quiescent HSC phenotype, with restored cytoplas-
mic lipid droplets and decreased cell proliferation. Mechanistically,
retinoid X receptor a (RXRa) was conﬁrmed to be the target of
miR-27a and 27b. These results indicated a new role and mecha-
nism of miR-27a and 27b in regulating fat metabolism and cell pro-
liferation during HSCs activation.
2. Materials and methods
2.1. Cell isolation and culture
Normal male Sprague–Dawley rats (body weight about 400 g)
were cared for according to the principles of Guide for the Care
and Use of Laboratory Animals formulated by Fudan University.
HSCs were isolated from the livers through two steps of digestion
as described previously [12]. By analysis through autoﬂuorescencelsevier B.V. All rights reserved.
Table 1
Sequence of primers used for PCR analyses.
Gene Primers Length of
production
Rat RXRa Sense 50-caacgggtcgaggctccatg-30 727 bp
Anti-
sense
50-gagctggggttcagccccat-30
Rat b-
actin
Sense 50-aggatgcagaaggagattactgc-30 219 bp
Anti-
sense
50-aaaacgcagctcagtaacagtgc-30
miR-9 Sensea 50-tctttggttatctagctgtatga-30 About
70 bpmiR-19a Sensea 50-tgtgcaaatctatgcaaaactga-30
miR-19b Sensea 50-gcaaatccatgcaaaactga-30
miR-27a Sensea 50-ttcacagtggctaagttccgc-30
miR-27b Sensea 50-ttcacagtggctaagttctgc-30
miR-30a Sensea 50-tgtaaacatcctcgactggaag-30
miR-30c Sensea 50-tgtaaacatcctacactctcagc-30
miR-30d Sensea 50-tgtaaacatccccgactggaag-30
miR-122 Sensea 50-tggagtgtgacaatggtgtttgt-30
miR-124 Sensea 50-gcacgcggtgaatgcc-30
miR-128a Sensea 50-tcacagtgaaccggtctctttt-30
miR-128b Sensea 50-tcacagtgaaccggtctctttc-30
miR-130a Sensea 50-cagtgcaatgttaaaagggcat-30
miR-130b Sensea 50-cagtgcaatgatgaaagggcat-30
miR-148b Sensea 50-tcagtgcatcacagaactttgt-30
miR-152 Sensea 50-tcagtgcatgacagaacttgg-30
miR-294 Sensea 50-aaagtgcttcccttttgtgtgt-30
miR-301 Sensea 50-cagtgcaatagtattgtcaaagcat-30
miR-302 Sensea 50-taagtgcttccatgttttggtga-30
miR-373 Sensea 50-gaagtgcttcgattttggggtgt-30
miR-450 Sensea 50-tttttgcgatgtgttcctaatg-30
miR-454 Sensea 50-tagtgcaatattgcttatagggttt-30
miR-455 Sensea 50-atgcagtccacgggcatatacact-30
miR-493 Sensea 50-ttgtacatggtaggctttcatt-30
miR-520a Sensea 50-aaagtgcttccctttggactgt-30
miR-520b Sensea 50-aaagtgcttccttttagaggg-30
miR-520c Sensea 50-aaagtgcttccttttagagggtt-30
miR-520d Sensea 50-aaagtgcttctctttggtgggtt-30
miR-520e Sensea 50-aaagtgcttcctttttgaggg-30
miR-520f Sensea 50-aagtgcttccttttagagggtt-30
miR-616 Sensea 50-actcaaaacccttcagtgactt-30
miR-721 Sensea 50-cagtgcaattaaaagggggaa-30
pre-miR-
27
Sense 50-gcagggcttagctgcttg-30 66 bp
Anti-
sense
50-ggcggaacttagccactgt-30
pre-miR-
128
Sense 50-tggattcggggccgtag-30 62 bp
Anti-
sense
50-aaagagaccggttcactgtgag-30
pre-miR-
301
Sense 50-gctctgactttattgcactactg-30 60 bp
Anti-
sense
50-gctttgacaatactattgcactg-30
U6snRNA Sense 50-ctcgcttcggcagcaca-30 94 bp
Anti-
sense
50-aacgcttcacgaatttgcgt-30
a Sense primers for mature miRNAs were provided here, anti-sense primer was
provided by Invitrogen as Universal q-PCR Primer, so the length of production was
not clear, according to our gel analysis, it was about 70 bp.
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ity of the isolated HSCs were more than 90% and 95%, respectively.
According to the changes of phenotype, HSCs maintained for 3 days
were regarded as quiescent HSCs, for 10 days as activated HSCs.
Passage two HSCs were used in transient transfection. Both HSCs
and human embryonic kidney cell line 293T were maintained in
DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fe-
tal bovine serum (Invitrogen).
2.2. Immunoﬂuorescence and Sudan III staining
HSCs grown on coverslips were ﬁxed with 2% paraformaldehyde
for 15 min on ice, followed by incubation with monoclonal anti-
bodies against desmin (Chemicon Temecula, CA, USA) at 37 C for
1 h, FITC labeled secondary antibody (Proteintech, Chicago, IL,
USA) at room temperature for 45 min, and ﬁnally mounted with
glycerol. Lipid droplets were stained with Sudan III solution for
2 min at room temperature.
2.3. RT-PCR and real-time RT-PCR
Total RNAs were extracted using TRIzol reagent (Invitrogen).
cDNAs were synthesized with Thermoscript RT-PCR system for
First-Strand cDNA Synthesis (Invitrogen) and NCode miRNA First-
Strand cDNA Synthesis kits (Invitrogen). For quantitative detection
of RXRa mRNAs and mature miRNAs, the templates and primer
sets (Table 1) were mixed with SYBR Premix Ex Taq (Takara, Tokyo,
Japan), and real-time PCR was performed using Rotor-Gene 3000
(Corbett Research, Sydney, Australia). For the detection of miRNA
precursors, RT-PCR was performed as reported [13] and the term
‘miRNA precursors’ was used to embrace both pri-miRNA and
pre-miRNA. The expression of mRNAs and miRNAs were normal-
ized to b-actin and U6snRNA, respectively.
2.4. Western blot analysis
Whole cell lysates were obtained by on ice scraping cells into
RIPA buffer. RXRa, collagen type I and alpha-smooth muscle actin
(a-SMA) proteins were analyzed by Western blot using RXRa
monoclonal antibody (Chemicon), collagen type I polyclonal anti-
body (Calbiochem, San Diego, CA, USA) and a-SMA monoclonal
antibody (Sigma, St. Louis, MO, USA). Signals were detected by
Super signal Western Pico chemiluminescent substrate (Pierce,
Rockford, IL). Control for loading was checked by re-probing the
membrane with b-actin antibody (Sigma).
2.5. Transient transfection of anti-miR miRNA Inhibitors
The passage one HSCs were re-seeded at a density of 2.5  104
cells per well in 24-well plates or 2.5  105 per 6-cm dishes. After
24 h, anti-miR miRNA speciﬁc Inhibitors, anti-miR-27a, anti-miR-
27b or negative control anti-miR-neg (Ambion, Austin, TX, USA)
were transiently transfected by Lipofectamine 2000 (Invitrogen)
into these passage two HSCs for 42 h, at a ﬁnal concentration of
50 nM, 75 nM or 100 nM.
2.6. Bromodeoxyuridine (BrdU) incorporation assay
For evaluation of cell proliferation, cells were incubated with
50 lg/ml BrdU (Sigma) to incorporate BrdU into DNA in cells en-
gaged in DNA synthesis (cells in S phase of the cell cycle) at the last
8 h of anti-miR miRNA Inhibitors transfection. BrdU incorporation
was determined by monoclonal antibody to BrdU (Sigma) and
Texas red-labeled secondary antibody (Proteintech). The nuclei
were counterstained with hoechst33258 (Sigma). For each well,
ﬁve areas were randomly counted at a magniﬁcation of 200. Theresults were expressed as the labeling index (LI) according to the
following formula: number of BrdU-positive nuclei 100/number
of total nuclei.
2.7. Plasmid construction
The putativemiR-27 anchor element from 2962 to 2990 of RXRa
mRNA 30UTR (50-GGCCTTGCTGCAGCTCGTCTGACTGTGAA-30) was
termed as miR-27 recognition element (MRE27) [14]. The synthe-
sized RXRa 30UTR fragment containing three copies of MRE27 with
ﬂanking Xho1 and Not1 restriction enzyme cohesive end were an-
nealed and ligated into the psiCHECK-2 Vector (Promega, Madison,
WI, USA) between the XhoI and NotI sites located 30 to the renilla
luciferase translational stop codon, resulting in single insertion as
psiCHECK-2/RXRaMRE27x3. In this vector, the post-transcriptional
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MRE27 fragment. The activity of renilla luciferase was normalized
by the internal ﬁreﬂy luciferase activity. MiR-27a and 27b expres-
sion plasmids, pcDNA6.2-GW/EmGFP-mir-27a and pcDNA6.2-GW/
EmGFP-mir-27b, were constructed according to manufacture’s
instructions (Invitrogen). pcDNA6.2-GW/EmGFP-mir-neg vector
was provided by Invitrogen as control. The nucleotide sequences
of constructed plasmids were conﬁrmed by DNA sequencing
(Invitrogen).
2.8. Luciferase assay
The 293T cells were seeded into 24-well plates 24 hs before
transfection and transiently cotransfected with 0.1 lg psiCHECK-
2/RXRaMRE27x3 reporter plasmid and 0.4 lg pcDNA6.2-GW/
EmGFP-mir-27a, mir-27b or mir-neg by Lipofectamine 2000
(Invitrogen). Luciferase assays were performed 42 h later using
the Dual-Luciferase reporter system (Promega). The renilla and
ﬁreﬂy luciferase signal were detected using the Veritas Microplate
Luminometer (Turner Biosystems, Sunnyvale, CA).
2.9. Statistics assay
Values were expressed as means ± S.D. Comparison between
means was made by ANOVA. When appropriate, ANOVA was
followed by Tukey’s posthoc test to do pair-wise comparisons be-
tween all groups. Differences were considered signiﬁcant if
P < 0.05. All assays were performed in triplicate and experiments
repeated at least three times with independently isolated cells.3. Results and discussion
3.1. MiR-27a and 27b were up-regulated in activated HSCs
Rat HSCs in primary culture were used to determine the miR-
NAs differently expressed during HSCs activation. The positiveFig. 1. Identiﬁcation and culture-activation of primary rat HSCs: (A) Autoﬂuorescenc
Immunoﬂuorescent staining of desmin in D10 HSCs, FITC. (C) Bunches of cytoplasmic lipi
in D10 HSCs, Sudan III staining. Original magniﬁcation 200. D3 and D10 HSCs represenidentiﬁcation of the cells was determined by autoﬂuerecence of
vitamin A and immunoﬂuerecent staining with intermediate ﬁla-
ment-desmin, a rat HSCs speciﬁc marker (Fig. 1A and B). With con-
tinued culture on plastic, cells appeared ‘‘activated” (i.e., increased
spreading and diminished vitamin A-riching lipid droplets) (Fig. 1C
and D) and began proliferating.
Mature miRNAs that differently expressed in quiescent and
activated HSCs were evaluated by real-time PCR. In activated HSCs,
some mature miRNAs were over-expressed with fold changes of
>1.5 (including miR-27a, 27b and miR-30a, 30c, 30d), while the
expression of a number of miRNAs were depressed (Fig. 2B and
Table 2). To investigate the potential function and mechanism of
these miRNAs during HSCs activation, we focused on miR-27a
and 27b which are two paralogous sequences of miR-27 that differ
at only one position and both over-expressed in activated HSCs.
The precursors for miR-27a and 27b were ampliﬁed using the same
pair of primers. In accordance with mature miR-27a and 27b, the
expression of their precursors also increased in activated HSCs
(Fig. 2C). MiR-27a and 27b has been reported to be involved in
the regulation of cell proliferation and differentiation in breast can-
cer and liver cancer [15–17]. We were interested to know if miR-27
also played a role in HSCs activation.
3.2. Down-regulation of miR-27a and 27b allows HSCs to restore their
ability to accumulate cytoplasmic lipid droplets and decreases HSCs
proliferation
To further determine the biological function of miR-27 during
HSCs activation, miR-27a and 27b were inactivated by anti-
miR-27a and anti-miR-27b in fully activated passage two HSCs.
The effects of anti-miR-27a and anti-miR-27b on the expression
of miR-27a and 27b were monitored and validated by quantitative
real-time PCR (Fig. 3A).
We ﬁrst examined whether suppression of miR-27a and 27b af-
fected the morphological features of activated HSCs. One of the
most distinct morphological features of activated HSCs was dimin-
ished cytoplasmic lipid droplets. In some activated HSCse of cytoplasmic vitamin A lipid droplets in D3 HSCs, excitated at 330 nm. (B)
d droplets in D3 HSCs, Sudan III staining. (D) Depletion of cytoplasmic lipid droplets
t day3 quiescent and day10 activated HSCs.
Fig. 2. Expression of miRNAs in D3 and D10 rat HSCs: (A) Five microgram total RNAs were loaded into each lane, the 1% agarose gel was stained with 0.1 lg/ml ethidium
bromide; (B) Expression of mature miRNAs in D3 and D10 rat HSCs were evaluated by real-time PCR; normalized to U6snRNA. (C) Expression of miRNA precursors in D3 and
D10 HSCs were analyzed by RT-PCR with 25 cycles (a) or 28 cycles (b). D3 and D10 HSCs represent day3 quiescent and day10 activated HSCs.
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small lipid droplets reappeared in perinuclear cytoplasm, as dem-
onstrated by Sudan III staining (Fig. 3B), and the number of Sudan
III positive-staining cells increased in a dose dependent manner
(Fig. 3C). These observations indicated a negative role of miR-27
in lipid anabolism regulation; down-regulation of miR-27a and
27b allows activated HSCs to restore their ability to accumulate
cytoplasmic lipid droplets. However, no signiﬁcant cytoplasmic li-
pid droplets could be found in HSCs transfected with either anti-
miR-27a or anti-miR-27b, which suggested that the blockage of
one paralog of over-expressed miR-27a or 27b is not sufﬁcient toTable 2
Differently expressed miRNAs in quiescent (D3) and activated (D10) HSCs.
MiRNA D3HSC average S.D. ± D10HSC average S.D. ± Folds increased
miR-130a 0.015 0.004 0.066 0.009 3.427
miR-27b 0.063 0.012 0.251 0.021 2.984*
miR-455 0.008 0.005 0.032 0.007 2.762
miR-30c 0.054 0.009 0.202 0.005 2.762*
miR-27a 0.071 0.012 0.248 0.023 2.494*
miR-450 0.008 0.003 0.027 0.005 2.392
miR-130b 0.020 0.008 0.060 0.012 2.046
miR-30a 0.069 0.017 0.192 0.030 1.783*
miR-30d 0.087 0.020 0.225 0.046 1.598*
miR-19b 0.054 0.015 0.026 0.005 0.517
miR-9 0.059 0.020 0.026 0.003 0.558
miR-721 0.031 0.012 0.013 0.005 0.571
miR-301 0.047 0.009 0.019 0.002 0.596
miR-520b 0.030 0.007 0.011 0.003 0.627
miR-520c 0.047 0.008 0.011 0.003 0.778
The expression of miRNAs were detected by real-time PCR, data normalized to
U6snRNA, *P < 0.05.induce above phenotypic switch in activated HSCs. MiR-27a and
27b share the same miRNA binding sites in the 30UTR of predicted
target mRNAs, increased expression of either of themwould down-
regulate their target genes. Both miR-27a and 27b were up-regu-
lated in activated HSCs, so cotransfection of anti-miR27a and
anti-miR27b were required to assess the role of these miRNAs in
HSCs. According to this preliminary ﬁnding, in the studies after-
ward, only anti-miR-27a and anti-miR-27b cotransfection groups
were set.
Another obvious and important parameters of HSCs activation
is increased cell proliferation. We next examined whether inacti-
vation of miR-27a and 27b inhibits this parameter. By BrdU
incorporation assay, we found that cotransfection of anti-miR-
27a and anti-miR-27b decreased the percentage of activated
HSCs in S phase of the cell cycle (Fig. 3D). In breast cancer cell
lines, both miR-27a and 27b were abundantly expressed and
have been reported to regulate several genes involved in cell pro-
liferation and differentiation [15,16]. Down-regulation of miR-
27a by antisense miR-27a decreased the percentage of MDA-
MB-231 cells in S phase of cell cycle [16]. In human hepatocellu-
lar carcinoma cells, miR-27a has also been proved to function as
proliferation-promoting factor [17]. So increased expression of
miR-27 may facilitate cell proliferation, thus exhibit oncogenic
activity. Our ﬁndings proved that increased expression of both
miR-27a and 27b also played a role in promoting cell prolifera-
tion during HSCs activation.
Hoechst33258 staining showed that cell apoptosis was not af-
fected by cotransfection of anti-miR-27a and anti-miR-27b, and
other characteristics of activated HSCs such as enhanced matrix
protein collagen type I expression and expression of a-smooth
muscle actin (a-SMA) were almost not affected (Fig. 3E).
Fig. 3. Down-regulation of miR-27a and 27b allows HSCs to restore their ability to accumulate cytoplasmic lipid droplets and decreases HSCs proliferation: (A) 75 nM anti-
miR-27a or anti-miR-27b transfection caused down-regulation of miR-27a or 27b in passage two HSCs, cells treated with transfection medium served as control, normalized
to U6snRNA. *P < 0.05 compared with anti-miR-neg. (B) Accumulation of cytoplasmic lipid droplets in passage two HSCs cotransfected with 75 nM anti-miR-27a, b, Sudan III
staining. Original magniﬁcation 400. (C) The number of Sudan III staining cells increased in a dose-dependent manner after cotransfected with anti-miR-27a, b, **P < 0.01
compared with the other two. (D) BrdU incorporation assay in passage two HSCs cotransfected with 75 nM anti-miR-27a, b, nuclei were counterstained with hoechst33258,
cells treated with transfection medium served as control, Original magniﬁcation 200. *P < 0.05 compared with anti-miR-neg. (E) D10 activated HSCs synthesized more
collagen type I and expressed a-SMA, **P < 0.01 compared with D3 HSCs. The expression of collagen type I and a-SMA were not affected in passage two HSCs cotransfected
with 75 nM anti-miR-27a, 27b for 42 h. The expression of collagen type I and a-SMA protein was determined byWestern blot analyses using whole cell lysates, b-actin served
as loading control. #P > 0.05 compared with those transfected with anti-miR-neg. D3 and D10 HSCs represent day3 quiescent and day10 activated HSCs; anti-miR-27a, b
represents anti-miR-27a and anti-miR-27b.
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Fig. 3 (continued)
Fig. 4. Interaction of miR-27a and 27b with the 30UTR of RXRamRNA: (A) Conserved site for miR-27 and miR-27 recognition element (MRE27) in rat RXRa 30UTR; predicted
pairing of miR-27a and 27b with target region in rat RXRa 30UTR. (B) Construct map of psiCHECK-2/RXRa MRE27x3 used for the luciferase assay. The 30UTR of RXRa was
cloned into the vector after the renilla luciferase gene (hRluc) to form a fusion transcript. Fireﬂy luciferase gene (hluc+) was coexpressed in the vector as an internal control.
(C) Transient transfection of miR-27a or 27b expression vectors signiﬁcantly increased miR-27a or 27b expression in 293Tcells. (D) Relative renilla luciferase activity of
psiCHECK-2/RXRa MRE27x3 in the presence of miR-27a, miR-27b or miR-neg expression vectors in 293T cells, the 293T cells simply transfected with psiCHECK-2/RXRa
MRE27x3 served as control, normalized to ﬁreﬂy luciferase activity. **P < 0.01 compared with those transfected with miR-neg expression vectors.
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receptor a (RXRa) mRNA
The results presented so far demonstrate that inactivation of
miR-27a and 27b in culture-activated HSC induces partial reversal
of the cell phenotype to that of quiescent HSC. In order to explore
the mechanisms involved, we performed computer-based se-
quence analysis by using Targetscan software [18]. The ﬁrst eight
nucleotide (seed sequence) from the 50end of both miR-27a and
27b miRNA are complementary to the 2983–2990 nucleotides of
the rat RXRa 30UTR which are conserved across various species
(Fig. 4A). Moreover, according to Targetscan, the context scores
[19] of miR-27a and 27b are the lowest among all the conserved
miRNAs predicted to target conserved sites in RXRa 30UTR, which
indicates that miR-27a and 27b are most likely to interact with
RXRa 30UTR and consequently down-regulate its expression at
post transcriptional level.
RXRa is involved in multiple signaling pathways related to cell
proliferation and differentiation, mainly as heterodimeric partner
of several nuclear receptors. It has been documented that RXRa
plays a central role in adipogenesis [20], probably as a heterodi-
meric partner for peroxisome proliferator-activated receptor c.
RXRa also suppresses DNA synthesis and causes cell growth arrest
in a variety of cell types including HSCs [21–24]. The expression of
RXRa signiﬁcantly decreases in activated HSCs [25] and transfec-
tion of RXRa gene can inhibit HSCs proliferation and partly reverse
the phenotype of activated HSCs [26]. However, the regulation of
RXRa expression remains to be established. It has been proposed
that reduced expression of RXRa relate to decreased mRNA stabil-
ity [22]. Potentially, in activated HSCs, down-regulation of RXRaFig. 5. Cotransfection of anti-miR-27a and anti-miR-27b up-regulated the expression of R
**P < 0.01 compared with D3 HSCs. (B) The expression of RXRawas up-regulated in passa
RXRa mRNA was determined by real-time PCR, normalized to b-actin; the expression of
actin served as loading control. **P < 0.01 compared with those transfected with anti-mi
miR-27a, b represents anti-miR-27a and anti-miR-27b.could occur through the binding of miR-27a or 27b to the 30UTR
of RXRa mRNA. And the phenotypic switch caused by inactivation
of miR-27a and 27b in activated HSCs might due, in part, to up-reg-
ulated RXRa.
To investigate the potential interaction experimentally, the
30UTR of rat RXRamRNA was subcloned after the renilla luciferase
coding sequence (Fig. 4B) and cotransfected with miR-27a or 27b
expression vectors into 293T cells. Indeed, renilla luciferase activ-
ity decreased by 40-50% in 293T cells cotransfected with either
miR-27a or miR-27b expression vectors compared with those
cotransfected with miR-neg expression vectors (Fig. 4D). These
ﬁndings show that both miR-27a and 27b can interact with the
30UTR of RXRa and efﬁciently inhibit the translation from the chi-
meric transcript.
To learn whether miR-27a and 27b can affect endogenous RXRa
expression, we next examined the effect of inactivation of miR-27a
and 27b on RXRa in culture-activated HSCs. Real-time PCR and
Western blots revealed signiﬁcantly increased expression of both
RXRa mRNA and protein in activated HSCs cotransfected by
anti-miR-27a and anti-miR-27b (Fig. 5). The results showed above
afﬁrmed a negative role of miR-27a and 27b in the regulation of
RXRa expression.
In conclusion, down-regulation of over-expressed miR-27a and
27b allowed activated HSCs to restore their ability to accumulate
cytoplasmic lipid droplets and decreased HSCs proliferation. More-
over, the fatty acid metabolism and cell proliferation regulating
properties of miR-27a and 27b maybe, at least partly mediated
by affecting RXRa expression. Silencing of miR-27a and 27b
in vivo may present a promising approach to the resolution of he-
patic ﬁbrosis.XRa in activated HSCs. (A) The expression of RXRa decreased in D10 activated HSCs.
ge two HSCs cotransfected with 75 nM anti-miR-27a, 27b for 42 h. The expression of
RXRa protein was determined by Western blot analyses using whole cell lysates, b-
R-neg. D3 and D10 HSCs represent day3 quiescent and day10 activated HSCs; anti-
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